Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
Professional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How AI-powered process optimization is transforming energy consumption management in continuous chemical manufacturing — key approaches, research directions, and innovation intelligence.
Article | Report Mapping the 2026 lipidomics profiling landscape: LC-HRMS, ion mobility, computational tools, clinical standardization, and emerging directions across 15+ countries.
Article | Report COMP360 psilocybin enters Phase III for treatment-resistant depression as MindMed's MM-120 advances in GAD. Analyse the readout race, trial design, and IP landscape.
Article | Report What are the main technical challenges of integrating neuromorphic computing chips into real-time robotic perception systems? A deep-dive for R&D and IP teams.
Article | Report Explore the graphene oxide functionalization landscape in 2026: patent strategies, application domains, and how R&D teams can build a rigorous GO intelligence pipeline.
Article | Report How Roche's trontinemab GRADUATE-3 Phase II trial compares to Kisunla and Leqembi: subcutaneous monthly dosing, TfR1 brain shuttle, and ARIA safety signals explained.
Article | Report Explore the key engineering differences between static and dynamic seal design in high-pressure cryogenic fluid systems — covering materials, leakage, and thermal cycling.
Article | Report Explore the 2026 technology landscape for biomass-derived carbon materials — biochar, activated carbon, hydrochar — and how PatSnap Eureka maps innovation.
Article | Report Mapping the 2026 continuous ketone monitor patent landscape: dual-analyte biosensors, breath acetone sensing, and wearable metabolic platforms reshaping diabetes care.
Article | Report Etavopivat (FT-4202) activates pyruvate kinase R to induce fetal hemoglobin without genome editing. Explore Phase 2/3 PEARL trial data and Novo Nordisk's IP strategy.
Article | Report Explore the 2026 landscape of CO₂ electroreduction catalyst materials: copper catalysts, SACs, MOFs, and key IP trends shaping carbon utilisation technology.
Article | Report No source data was provided for this topic. This page explains why the article cannot be produced and what steps are needed to generate a fully evidenced report.
Article | Report A 56-year patent and literature landscape of RLV heat shield technology: active cooling, deployable shields, ablative TPS, and emerging IP frontiers for 2026.
Article | Report Model predictive control vs reinforcement learning for industrial process optimization: key technical differences, trade-offs, and when to use each strategy.
Article | Report SGLT2 inhibitors empagliflozin and dapagliflozin are reshaping cardiorenal medicine. Explore the Phase III landscape, competitive IP signals, and what to do when data pipelines fail.